Explore more publications!

IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on October 18, 2025

Rising Global Demand for Next-Generation Casino Software Solutions
Ecer.com Leads the Mobile B2B Revolution in Global Trade
AV-Comparatives Publishes Consumer Antivirus Tests: Which Cybersecurity Software Keeps You Safe Without Slowing You Down
Free Welcome Bonus No Deposit Required Real Money Online Casino By Cafe Casino
Free Spins No Deposit Bonus Casino Canada By Cafe Casino
Crypto Casino No Deposit Bonus | Bitcoin Casino No Deposit Bonus 2025 By Cafe Casino
Free Spins No Deposit UK | Real Money Online Casino In UK By Cafe Casino
Fast Payout Casinos 2025: All iGaming Releases Exclusive Update on the Instant Withdrawal Casinos
Herpafend Addresses Herpes Outbreak Prevention as Natural Remedies Market Reaches $1.23 Billion
Empower Business Resilience with SOC as a Service for Advanced Cyber Defense
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
DeFi crypto Mutuum Finance (MUTM) Onboards Over 17,300 Investors With 70% of Phase 6 Allocated
iFLYTEK AINOTE 2 kommt auf den Markt: Eine bahnbrechende Neuerung für die Produktivität im Beruf
Lancement de l’iFLYTEK AINOTE 2 : véritable révolution pour la productivité professionnelle
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
Celcuity Provides Update on Status of the PIK3CA Mutated Cohort of Phase 3 VIKTORIA-1 Trial and Releases Additional Data Analysis From Phase 1b Clinical Trial
Celcuity Presents Updated Data at the 2025 ESMO Congress from Phase 1 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration Resistant Prostate Cancer (“mCRPC”)
Detailed Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/HER2- Advanced Breast Cancer
Kura Oncology Announces Preliminary Data from Its Farnesyl Transferase Inhibitor (FTI) Programs at the 2025 European Society for Medical Oncology (ESMO) Congress
AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions